Five Prime Therapeutics, Inc. Research and Development Expense
Five Prime Therapeutics, Inc. reported Research and Development Expense of $65.49 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-03-22
- Five Prime Therapeutics, Inc. research and development expense for the quarter ending 2020-12-31 was $12.92M, a 50.20% decline year-over-year.
- Five Prime Therapeutics, Inc. research and development expense for the quarter ending 2020-09-30 was $21.45M, a 20.42% decline year-over-year.
- Five Prime Therapeutics, Inc. research and development expense for the quarter ending 2020-06-30 was $12.57M, a 57.27% decline year-over-year.
- Five Prime Therapeutics, Inc. research and development expense for the quarter ending 2020-03-31 was $18.56M, a 41.56% decline year-over-year.
- Five Prime Therapeutics, Inc. research and development expense for fiscal 2020 was $65.49M, a 42.58% decline from fiscal 2019.
- Five Prime Therapeutics, Inc. research and development expense for fiscal 2019 was $114.06M, a 27.05% decline from fiscal 2018.
- Five Prime Therapeutics, Inc. research and development expense for fiscal 2018 was $156.35M, a 3.61% increase from fiscal 2017.
- Five Prime Therapeutics, Inc. research and development expense for fiscal 2017 was $150.91M, a 60.42% increase from fiscal 2016.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $12.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $34.36M derived: sum of 2 quarters · filed 2021-03-22 | $46.94M derived: sum of 3 quarters · filed 2021-03-22 | $65.49M 10-K · filed 2021-03-22 | |
| 2020-09-30 | $21.45M 10-Q · filed 2020-11-03 | $34.02M derived: sum of 2 quarters · filed 2020-11-03 | $52.58M 10-Q · filed 2020-11-03 | $78.51M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-06-30 | $12.57M 10-Q · filed 2020-08-06 | $31.13M 10-Q · filed 2020-08-06 | $57.07M derived: sum of 3 quarters · filed 2021-03-22 | $84.01M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-03-31 | $18.56M 10-Q · filed 2020-05-07 | $44.49M derived: sum of 2 quarters · filed 2021-03-22 | $71.44M derived: sum of 3 quarters · filed 2021-03-22 | $100.87M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2019-12-31 | $25.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $52.88M derived: sum of 2 quarters · filed 2021-03-22 | $82.31M derived: sum of 3 quarters · filed 2021-03-22 | $114.06M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $26.95M 10-Q · filed 2020-11-03 | $56.37M derived: sum of 2 quarters · filed 2020-11-03 | $88.13M 10-Q · filed 2020-11-03 | $122.86M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2019-06-30 | $29.43M 10-Q · filed 2020-08-06 | $61.18M 10-Q · filed 2020-08-06 | $95.91M derived: sum of 3 quarters · filed 2021-03-22 | $140.60M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2019-03-31 | $31.75M 10-Q · filed 2020-05-07 | $66.49M derived: sum of 2 quarters · filed 2021-03-22 | $111.17M derived: sum of 3 quarters · filed 2021-03-22 | $144.55M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2018-12-31 | $34.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $79.42M derived: sum of 2 quarters · filed 2021-03-22 | $112.80M derived: sum of 3 quarters · filed 2021-03-22 | $156.35M 10-K · filed 2021-03-22 | |
| 2018-09-30 | $44.69M 10-Q · filed 2019-11-06 | $78.07M derived: sum of 2 quarters · filed 2019-11-06 | $121.62M 10-Q · filed 2019-11-06 | $154.29M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $33.38M 10-Q · filed 2019-08-08 | $76.93M 10-Q · filed 2019-08-08 | $109.60M derived: sum of 3 quarters · filed 2020-02-27 | $152.34M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $43.55M 10-Q · filed 2019-05-09 | $76.22M derived: sum of 2 quarters · filed 2020-02-27 | $118.96M derived: sum of 3 quarters · filed 2020-02-27 | $160.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $32.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $75.40M derived: sum of 2 quarters · filed 2020-02-27 | $117.15M derived: sum of 3 quarters · filed 2020-02-27 | $150.91M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $42.73M 10-Q · filed 2018-11-06 | $84.48M derived: sum of 2 quarters · filed 2018-11-06 | $118.24M 10-Q · filed 2018-11-06 | $147.39M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $41.74M 10-Q · filed 2018-08-08 | $75.50M 10-Q · filed 2018-08-08 | $104.65M derived: sum of 3 quarters · filed 2019-02-26 | $128.54M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | $33.76M 10-Q · filed 2018-05-08 | $62.91M derived: sum of 2 quarters · filed 2019-02-26 | $86.80M derived: sum of 3 quarters · filed 2019-02-26 | $108.98M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | $29.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $53.04M derived: sum of 2 quarters · filed 2019-02-26 | $75.22M derived: sum of 3 quarters · filed 2019-02-26 | $94.07M 10-K · filed 2019-02-26 | |
| 2016-09-30 | $23.89M 10-Q · filed 2017-11-06 | $46.07M derived: sum of 2 quarters · filed 2017-11-06 | $64.92M 10-Q · filed 2017-11-06 | $85.88M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | $22.18M 10-Q · filed 2017-08-08 | $41.03M 10-Q · filed 2017-08-08 | $61.99M derived: sum of 3 quarters · filed 2018-02-27 | $86.71M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $18.86M 10-Q · filed 2017-05-05 | $18.28M 10-Q · filed 2016-05-06 | $39.81M derived: sum of 2 quarters · filed 2018-02-27 | $64.53M derived: sum of 3 quarters · filed 2018-02-27 | $77.84M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $20.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $45.68M derived: sum of 2 quarters · filed 2018-02-27 | $58.99M derived: sum of 3 quarters · filed 2018-02-27 | $70.20M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $24.72M 10-Q · filed 2016-11-04 | $38.03M derived: sum of 2 quarters · filed 2016-11-04 | $49.24M 10-Q · filed 2016-11-04 | $61.81M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-06-30 | $13.31M 10-Q · filed 2016-08-05 | $24.52M 10-Q · filed 2016-08-05 | $37.09M derived: sum of 3 quarters · filed 2017-02-24 | $46.90M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-03-31 | $11.21M 10-Q · filed 2016-05-06 | $23.78M derived: sum of 2 quarters · filed 2017-02-24 | $33.59M derived: sum of 3 quarters · filed 2017-02-24 | $45.46M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2014-12-31 | $12.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $22.37M derived: sum of 2 quarters · filed 2017-02-24 | $34.25M derived: sum of 3 quarters · filed 2017-02-24 | $43.17M 10-K · filed 2017-02-24 | |
| 2014-09-30 | $9.80M 10-Q · filed 2015-11-05 | $21.68M derived: sum of 2 quarters · filed 2015-11-05 | $30.60M 10-Q · filed 2015-11-05 | $38.68M derived: sum of 4 quarters · filed 2016-03-11 | |
| 2014-06-30 | $11.87M 10-Q · filed 2015-08-07 | $20.80M 10-Q · filed 2015-08-07 | $28.88M derived: sum of 3 quarters · filed 2016-03-11 | $37.07M derived: sum of 4 quarters · filed 2016-03-11 | |
| 2014-03-31 | $8.93M 10-Q · filed 2015-05-14 | $17.00M derived: sum of 2 quarters · filed 2016-03-11 | $25.20M derived: sum of 3 quarters · filed 2016-03-11 | $33.78M derived: sum of 4 quarters · filed 2016-03-11 | |
| 2013-12-31 | $8.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $16.27M derived: sum of 2 quarters · filed 2016-03-11 | $24.86M derived: sum of 3 quarters · filed 2016-03-11 | $32.78M 10-K · filed 2016-03-11 | |
| 2013-09-30 | $8.19M 10-Q · filed 2014-11-12 | $16.78M derived: sum of 2 quarters · filed 2014-11-12 | $24.71M 10-Q · filed 2014-11-12 | $32.19M derived: sum of 4 quarters · filed 2015-03-18 | |
| 2013-06-30 | $8.59M 10-Q · filed 2014-08-07 | $16.52M 10-Q · filed 2014-08-07 | $23.99M derived: sum of 3 quarters · filed 2015-03-18 | $30.50M derived: sum of 4 quarters · filed 2015-03-18 | |
| 2013-03-31 | $7.93M 10-Q · filed 2014-05-12 | $15.41M derived: sum of 2 quarters · filed 2015-03-18 | $21.92M derived: sum of 3 quarters · filed 2015-03-18 | ||
| 2012-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $13.99M derived: sum of 2 quarters · filed 2015-03-18 | $28.78M 10-K · filed 2015-03-18 | ||
| 2012-09-30 | $6.51M 10-Q · filed 2013-11-13 | $21.30M 10-Q · filed 2013-11-13 | |||
| 2011-12-31 | $34.04M 10-K · filed 2014-03-26 |